Pictet Asset Management (Switzerland)’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $359K | Buy |
27,025
+3,692
| +16% | +$49.1K | ﹤0.01% | 1414 |
|
|
2023
Q1 | $270K | Hold |
23,333
| – | – | ﹤0.01% | 1554 |
|
|
2022
Q4 | $191K | Buy |
23,333
+10,933
| +88% | +$89.5K | ﹤0.01% | 1739 |
|
|
2022
Q3 | $72K | Hold |
12,400
| – | – | ﹤0.01% | 1495 |
|
|
2022
Q2 | $55K | Sell |
12,400
-118,320
| -91% | -$525K | ﹤0.01% | 1526 |
|
|
2022
Q1 | $1.19M | Hold |
130,720
| – | – | ﹤0.01% | 1032 |
|
|
2021
Q4 | $2.68M | Sell |
130,720
-538,440
| -80% | -$11M | ﹤0.01% | 949 |
|
|
2021
Q3 | $17.1M | Buy |
+669,160
| New | +$17.1M | 0.02% | 547 |
|